Posts Feed
Comments Feed

Archive for the 'Immune System / Vaccines' Category

Prophylactic Antibiotics, Air Quality Control And Barrier Isolation Combined Reduce Mortality In High-Risk Cancer Patients Receiving Chemotherapy

A combination of prophylactic antibiotics, barrier isolation and air quality control measures substantially reduces the risk of death in high-risk cancer patients who are immunocompromised due to chemotherapy or stem cell transplantation. This reduction is 40% at 30 days post-treatment. But it is the antibiotic administration that is needed to show the effect on mortality - without this, the effect diminishes.

More: continued here

No Comments »

Mouse Trap? Stanford Immunologist Calls For More Research On Humans, Not Mice

The fabled laboratory mouse-from which we have learned so much about how the immune system works-can teach us only so much about how we humans get sick and what to do about it, says a leading researcher at the Stanford University School of Medicine.

More: continued here

No Comments »

VLST Corporation And Novo Nordisk Announce Collaboration Agreement To Develop Therapeutics For Autoimmune And Inflammatory Disorders

Novo Nordisk and VLST Corporation, a Seattle-based biotechnology company focused on the development of therapeutics for autoimmune and inflammatory disorders, announced that the companies have entered into an exclusive, worldwide collaboration agreement to develop therapeutic targets utilizing VLST’s technology platform in the fields of autoimmune and inflammatory disorders.

More: continued here

No Comments »

« Prev - Next »

1